Panulde, Rachel .
HRN: 27-92-11 Sex: FemalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/16/2025
CEFUROXIME 1.5GM (VIAL)
10/16/2025
10/17/2025
IVTT
1.5g
Q8h
SP LTCS
Waiting Final Action
10/19/2025
CEFUROXIME 500MG (TAB)
10/19/2025
10/24/2025
PO
500mg
BID
SP LTCS
Waiting Final Action
10/19/2025
METRONIDAZOLE 500MG (TAB)
10/19/2025
10/24/2025
PO
500mg
TID
SP LTCS
Waiting Final Action